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Effective adjuvants are needed to design effective vaccines
against Chlamydia trachomatis (Ct). The aim of this study
was to observe the immune response stimulated by inocu-
lation of a DNA vaccine encoding a fusion protein com-
prising multiple Ct major outer membrane protein
(MOMP) epitopes and human papillomavirus 6b L1 (HPV
6 bL 1 )a st h eb a s i sf o rd e s i g n i n gan o v e lD N Av a c c i n e
against genital Chlamydia infections. The recombinant
sequence encoding MOMP multi-epitopes was tandemly
inserted and engaged downstream of HPV 6b L1 to con-
struct a plasmid vaccine. COS-7 cells were transfected with
pcDNA3.1(+)/Ct MOMP 168 encoding the Ct MOMP
multi-epitope gene and co-expressed with the nucleic vac-
cine plasmid pcDNA3.1(+)/HPV 6b L1/Ct MOMP 168,
which contains both the HPV 6b L1 and Ct MOMP multi-
epitope genes. In addition, BALB/ c mice were inoculated
intramuscularly (i.m.) with pcDNA3.1(+)/HPV 6b L1/Ct
MOMP 168 or pcDNA3.1(+)/Ct MOMP 168. Serum IgG
and secretory IgA (sIgA) in vaginal washes were then mea-
sured. The expression of HPV 6b L1/Ct MOMP multi-epi-
tope was confirmed by western blotting, confocal
microscopy and RT-PCR. Mice vaccinated with pcDNA3.1
(+)/HPV 6b L1/Ct MOMP 168 had significantly higher
IgG and sIgA antibody titers than pcDNA3.1(+)/Ct
MOMP 16 controls. The results show that genetic fusion
of the molecular adjuvant HPV 6b L1 to Ct MOMP 168
significantly increases the antigen-specific antibody
response induced by the Ct MOMP 168 DNA vaccine.
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